CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data.
Decision to Cover New Colorectal Cancer Drugs, PET Scans.
Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies.
Trending Stories
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- What are you reading in 2023?
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence